GENN

Genesis Healthcare, Inc. [GENN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

GENN Stock Summary

Top 10 Correlated ETFs

GENN


Top 10 Correlated Stocks

GENN


In the News

04:01 29 May 2023 GENN

Genesis HealthCare Announces Universal COVID-19 Vaccination for Employees, Care Partners and Onsite Vendors

KENNETT SQUARE, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Genesis HealthCare, (“Genesis” or “Company”) (OTC PINK: GENN), a national post-acute care provider, announced today that it is adopting a universal COVID-19 vaccination requirement for employees, care partners, and onsite vendors across the Company.

GENN Financial details

Company Rating
-
Market Cap
2.04M
Income
-108.54M
Revenue
3.91B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
44K
Optionable
No
Shortable
Yes
Earnings
17 Mar 2022
P/E
0
Forward P/E
-
PEG
-
P/S
56075.57
P/B
-
P/C
-
P/FCF
0.01
Quick Ratio
0.17
Current Ratio
0.23
Debt / Equity
-6.37
LT Debt / Equity
-1.01
-
-
EPS (TTM)
-0.8
EPS next Y
-
EPS next Q
-
EPS this Y
-1419.94%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
17.3%
Revenue last 5Y
-7.38%
Revenue Q/Q
-2.09%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-1%
ROE
7%
ROC
-1.24%
Gross Margin
42%
Oper. Margin
-7%
Profit Margin
-2%
Payout
-
Shs Outstand
1.36B
Shs Float
111.78M
-
-
-
-
Target Price
-
52W Range
0.001-0.1
52W High
-
52W Low
-
RSI
23.34
Rel Volume
0.11
Avg Volume
36.12K
Volume
3.93K
Perf Week
-77.27%
Perf Month
-77.27%
Perf Quarter
-86.49%
Perf Half Y
-86.49%
-
-
-
-
Beta
-0.953905
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0015
Change
0%

GENN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2020-12-31

Metric History 2016-12-312017-12-312018-12-312019-12-31 2020-12-31
Revenue per share
37.157.0449.2742.5634.92
Net income per share
-0.41-6.15-2.330.07-0.92
Operating cash flow per share
0.441.280.18-0.072.82
Free cash flow per share
-0.160.6-0.32-0.652.33
Cash per share
0.330.580.560.411.9
Book value per share
-3.17-11.51-13.26-10.09-7.33
Tangible book value per share
-8.71-20.26-22.27-11.7-11.89
Share holders equity per share
-3.17-11.51-13.26-10.09-7.33
Interest debt per share
36.0358.7653.2143.4235.28
Market cap
656.76M71.88M119.19M175.95M54.21M
Enterprise value
5.64B5.05B5.01B4.34B3.65B
P/E ratio
-10.26-0.12-0.5123.54-0.52
Price to sales ratio
0.110.010.020.040.01
POCF ratio
9.610.66.41-24.550.17
PFCF ratio
-26.531.28-3.66-2.520.21
P/B Ratio
-1.34-0.07-0.09-0.16-0.07
PTB ratio
-1.34-0.07-0.09-0.16-0.07
EV to sales
0.980.941.010.950.93
Enterprise value over EBITDA
8.0530.4911.2112.4323.98
EV to operating cash flow
82.5741.96269.52-605.0211.57
EV to free cash flow
-228.0189.69-153.8-62.0314.04
Earnings yield
-0.1-8.06-1.970.04-1.91
Free cash flow yield
-0.040.78-0.27-0.44.8
Debt to equity
-13.28-5.97-4.71-5.31-6.37
Debt to assets
1.131.351.481.231.29
Net debt to EBITDA
7.1130.0610.9411.9323.63
Current ratio
1.231.050.960.770.23
Interest coverage
0.480.370.451.250.33
Income quality
-1.07-0.21-0.08-0.96-3.05
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.060.060.060.120.14
Research and developement to revenue
00000
Intangibles to total assets
0.110.050.050.040.04
Capex to operating cash flow
-1.36-0.53-2.758.75-0.18
Capex to revenue
-0.02-0.01-0.01-0.01-0.01
Capex to depreciation
-0.37-0.25-0.23-0.51-0.52
Stock based compensation to revenue
00000
Graham number
5.4439.8926.363.9812.35
ROIC
0.040.040.050.040.01
Return on tangible assets
-0.01-0.13-0.060-0.03
Graham Net
-37.75-62.31-57.27-49.17-41.95
Working capital
201.43M40.71M-36.59M-242.32M-2.98B
Tangible asset value
-1.35B-1.91B-2.25B-1.26B-1.33B
Net current asset value
-5.45B-5.53B-5.43B-4.92B-4.36B
Invested capital
-10.28-4.65-3.67-4.14-4.65
Average receivables
810.75M778.12M673.43M595.18M497.28M
Average payables
246.21M272.13M260.21M236.59M224.87M
Average inventory
00000
Days sales outstanding
52.9849.1945.6745.3839.89
Days payables outstanding
28.0134.3330.7535.0134.19
Days of inventory on hand
00000
Receivables turnover
6.897.427.998.049.15
Payables turnover
13.0310.6311.8710.4210.67
Inventory turnover
00000
ROE
0.130.530.18-0.010.13
Capex per share
-0.6-0.68-0.51-0.58-0.5

Quarterly Fundamentals Overview

Last date of statement is 2020-12-31 for Q4

Metric History 2019-12-312020-03-312020-06-302020-09-30 2020-12-31
Revenue per share
10.389.958.68.30
Net income per share
-0.160.31-0.26-0.850
Operating cash flow per share
-0.210.142.92-0.530
Free cash flow per share
-0.35-0.052.83-0.610
Cash per share
0.40.52.261.780
Book value per share
-9.9-6.63-6.79-10.120
Tangible book value per share
-11.48-11.06-11.15-11.610
Share holders equity per share
-9.9-6.63-6.79-10.120
Interest debt per share
41.2939.3236.5234.940
Market cap
179.38M92.45M76.75M61.57M0
Enterprise value
4.34B4.35B3.86B3.64B3.6B
P/E ratio
-2.580.69-0.65-0.160
Price to sales ratio
0.160.080.080.070
POCF ratio
-7.836.060.24-1.040
PFCF ratio
-4.65-15.340.24-0.890
P/B Ratio
-0.17-0.13-0.1-0.050
PTB ratio
-0.17-0.13-0.1-0.050
EV to sales
3.823.984.033.883.91
Enterprise value over EBITDA
95.9966.951.4471.8777
EV to operating cash flow
-189.28285.0511.85-61.23104.07
EV to free cash flow
-112.4-721.1312.26-52.46171.36
Earnings yield
-0.10.36-0.38-1.560
Free cash flow yield
-0.22-0.074.1-1.130
Debt to equity
-5.31-7.6-7.2-4.68-6.37
Debt to assets
1.231.231.251.271.29
Net debt to EBITDA
92.0265.4850.4170.6577
Current ratio
0.770.790.90.940.23
Interest coverage
0.60.212.280.770.69
Income quality
1.320.39-11.10.62-2.06
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.120.130.140.140.15
Research and developement to revenue
00000
Intangibles to total assets
0.040.040.040.040.04
Capex to operating cash flow
0.68-1.4-0.030.17-0.39
Capex to revenue
-0.01-0.02-0.01-0.01-0.01
Capex to depreciation
0.24-0.37-4.68-0.41-0.57
Stock based compensation to revenue
00000
Graham number
5.946.756.3413.890
ROIC
0.0100.020.010.01
Return on tangible assets
00.01-0.01-0.020
Graham Net
-48.23-46.12-43.52-42.570
Working capital
-242.32M-203.91M-106.54M-53.46M-2.98B
Tangible asset value
-1.26B-1.21B-1.24B-1.31B-1.33B
Net current asset value
-4.92B-4.76B-4.51B-4.46B-4.36B
Invested capital
-4.14-5.88-5.34-3.42-4.65
Average receivables
556.45M560.58M506.44M457.69M441.48M
Average payables
246.41M216.87M203.11M200.57M200.81M
Average inventory
00000
Days sales outstanding
44.9945.6143.2343.7241.81
Days payables outstanding
3630.2930.7632.0136.32
Days of inventory on hand
00000
Receivables turnover
21.972.082.062.15
Payables turnover
2.52.972.932.812.48
Inventory turnover
00000
ROE
0.02-0.050.040.080.02
Capex per share
-0.14-0.19-0.1-0.090

GENN Frequently Asked Questions

What is Genesis Healthcare, Inc. stock symbol ?

Genesis Healthcare, Inc. is a US stock , located in Kennett square of Pa and trading under the symbol GENN

What is Genesis Healthcare, Inc. stock quote today ?

Genesis Healthcare, Inc. stock price is $0.0015 today.

Is Genesis Healthcare, Inc. stock public?

Yes, Genesis Healthcare, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap